8-K: Surgery Partners Appoints Dr. Laura L. Forese to Board of Directors

Surgery Partners expands its board with the appointment of Dr. Laura L. Forese, bringing extensive healthcare experience to the company.

Summary

• Surgery Partners, Inc. has appointed Dr. Laura L. Forese as an independent director to its Board of Directors, effective January 10, 2025.
• The appointment increases the size of the Surgery Partners Board to eleven members.
• Dr. Forese's term as a Class II director will expire at the 2026 annual meeting of stockholders.
• She will also serve as a member of the Compliance and Ethics Committee of the Board.
• Dr. Forese's compensation will be consistent with other non-employee directors.
• Dr. Forese has over 40 years of healthcare administration experience, most recently as an executive vice president and chief operating officer for New York-Presbyterian.
• Surgery Partners is a healthcare services company focused on outpatient surgical and related ancillary care, with over 200 locations in 33 states.

Sentiment

Score: 7

Explanation: The announcement is positive due to the addition of an experienced healthcare executive to the board, suggesting a focus on growth and operational excellence. There are no immediate financial implications, but the appointment signals a commitment to strategic leadership.

Positives

• The addition of Dr. Forese brings extensive healthcare experience to Surgery Partners' Board.
• Dr. Forese's background as an orthopedic surgeon and healthcare executive aligns with Surgery Partners' focus on surgical care.
• Her experience in patient safety, efficiency, and transformation could benefit Surgery Partners' operations.
• Dr. Forese's appointment increases the board size, potentially bringing diverse perspectives.

Future Outlook

Surgery Partners aims to continue its growth in short-stay surgical cases and provide high-quality, efficient operations.

Management Comments

• Wayne DeVeydt, Chairman of Surgery Partners' Board of Directors, stated that Dr. Forese's experience and insights will inform the company's continued growth in short-stay surgical cases.
• Dr. Forese stated that Surgery Partners is well-positioned to support surgeons in establishing high-quality ambulatory surgical centers and providing savings for patients and payors.

Industry Context

The appointment of Dr. Forese reflects a broader trend of healthcare companies seeking experienced leaders to navigate the evolving landscape of surgical care and outpatient services. Surgery Partners is positioning itself to capitalize on the shift towards ambulatory surgical centers, which offer cost-effective solutions for patients and payors.

Comparison to Industry Standards

• New York-Presbyterian, where Dr. Forese previously served, is one of the nation's most comprehensive, integrated academic healthcare systems, comparable to systems like Mayo Clinic and Cleveland Clinic.
• Surgery Partners' focus on ambulatory surgery centers aligns with the industry trend of shifting procedures to lower-cost outpatient settings, similar to companies like AmSurg and United Surgical Partners International.
• The company's growth strategy mirrors that of other large surgical services businesses aiming to consolidate and expand their footprint in the fragmented outpatient market.

Management Changes

Stakeholder Impact

• Shareholders may view the appointment positively, anticipating strategic benefits from Dr. Forese's expertise.
• Employees may see the appointment as a sign of continued growth and stability.
• Patients could benefit from Dr. Forese's focus on patient safety and efficient operations.
• Physicians may find Surgery Partners more attractive due to the company's commitment to high-quality ambulatory surgical centers.

Key Dates